BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $188,700 | -17.2% | 5,000 | 0.0% | 0.02% | -25.0% |
| Q2 2023 | $227,800 | -69.0% | 5,000 | -72.4% | 0.02% | -70.7% |
| Q1 2023 | $734,136 | -20.4% | 18,100 | 0.0% | 0.08% | -23.4% |
| Q4 2022 | $922,557 | -64.7% | 18,100 | -62.7% | 0.11% | -65.5% |
| Q3 2022 | $2,612,000 | -16.1% | 48,500 | 0.0% | 0.31% | -14.1% |
| Q2 2022 | $3,115,000 | -17.2% | 48,500 | 0.0% | 0.36% | +0.8% |
| Q1 2022 | $3,761,000 | -9.7% | 48,500 | 0.0% | 0.36% | +0.6% |
| Q4 2021 | $4,163,000 | -22.4% | 48,500 | -27.3% | 0.36% | -23.3% |
| Q3 2021 | $5,365,000 | -41.6% | 66,700 | -41.6% | 0.46% | -44.6% |
| Q2 2021 | $9,193,000 | -4.6% | 114,200 | 0.0% | 0.84% | -0.2% |
| Q1 2021 | $9,632,000 | -1.8% | 114,200 | -6.5% | 0.84% | -29.0% |
| Q4 2020 | $9,805,000 | -0.2% | 122,200 | 0.0% | 1.18% | -11.0% |
| Q3 2020 | $9,827,000 | -7.0% | 122,200 | -0.4% | 1.33% | -14.5% |
| Q2 2020 | $10,564,000 | +6.0% | 122,700 | 0.0% | 1.56% | -25.0% |
| Q1 2020 | $9,962,000 | -12.2% | 122,700 | -9.6% | 2.07% | +25.2% |
| Q4 2019 | $11,347,000 | -5.3% | 135,700 | -0.9% | 1.66% | -12.6% |
| Q3 2019 | $11,979,000 | +5.6% | 136,950 | -1.2% | 1.89% | +3.7% |
| Q2 2019 | $11,347,000 | +0.7% | 138,550 | 0.0% | 1.83% | -5.5% |
| Q1 2019 | $11,266,000 | +23.5% | 138,550 | 0.0% | 1.93% | +10.6% |
| Q4 2018 | $9,119,000 | -14.6% | 138,550 | 0.0% | 1.75% | +1.1% |
| Q3 2018 | $10,681,000 | +4.4% | 138,550 | 0.0% | 1.73% | -5.1% |
| Q2 2018 | $10,231,000 | +10.0% | 138,550 | -3.1% | 1.82% | +5.0% |
| Q1 2018 | $9,301,000 | +0.6% | 143,000 | 0.0% | 1.73% | +4.0% |
| Q4 2017 | $9,244,000 | +3.7% | 143,000 | +0.7% | 1.67% | -0.2% |
| Q3 2017 | $8,911,000 | +29.2% | 142,000 | +24.7% | 1.67% | +26.7% |
| Q2 2017 | $6,896,000 | +16.7% | 113,900 | 0.0% | 1.32% | +21.1% |
| Q1 2017 | $5,907,000 | +7.4% | 113,900 | -8.1% | 1.09% | +4.6% |
| Q4 2016 | $5,498,000 | -9.2% | 124,000 | -2.5% | 1.04% | +3.2% |
| Q3 2016 | $6,055,000 | +2.8% | 127,200 | -2.3% | 1.01% | +5.8% |
| Q2 2016 | $5,888,000 | +7.6% | 130,200 | -2.3% | 0.96% | +6.5% |
| Q1 2016 | $5,472,000 | +7.7% | 133,200 | 0.0% | 0.90% | +13.4% |
| Q4 2015 | $5,082,000 | +10.3% | 133,200 | -5.0% | 0.79% | +27.4% |
| Q3 2015 | $4,606,000 | -53.0% | 140,200 | 0.0% | 0.62% | -47.6% |
| Q2 2015 | $9,804,000 | +19.1% | 140,200 | +16.6% | 1.18% | +17.9% |
| Q1 2015 | $8,234,000 | +16.5% | 120,200 | +24.7% | 1.00% | +14.0% |
| Q4 2014 | $7,065,000 | +11.4% | 96,400 | +9.0% | 0.88% | +2.0% |
| Q3 2014 | $6,344,000 | +39.3% | 88,400 | +40.3% | 0.86% | +39.6% |
| Q2 2014 | $4,555,000 | +3.2% | 63,000 | +5.0% | 0.62% | -2.8% |
| Q1 2014 | $4,415,000 | +5.8% | 60,000 | 0.0% | 0.64% | +0.3% |
| Q4 2013 | $4,173,000 | +5.9% | 60,000 | 0.0% | 0.64% | +0.2% |
| Q3 2013 | $3,941,000 | -6.7% | 60,000 | -1.6% | 0.63% | -7.4% |
| Q2 2013 | $4,225,000 | – | 61,000 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |